Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06767514 |
| Title | Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 (HARMONi-7) |
| Acronym | HARMONi-7 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Summit Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Summit Therapeutics Research Center | NOT_YET_RECRUITING | Cerritos | California | 90703 | United States | Details |
| Summit Therapeutics Research Center | NOT_YET_RECRUITING | Los Angeles | California | 90067 | United States | Details |
| Summit Therapeutics Research Center | RECRUITING | Tamarac | Florida | 33321 | United States | Details |